Quantum Biopharma (QNTM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.47, -8.86% vs the prior close of $2.71.
- Volume 190.41K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
QNTM slides 8.9% to $2.47, a 6-month low. Closed at $2.47, -8.86% vs the prior close of $2.71. Day range $2.46–$2.75, opened at $2.68.
QNTM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — QNTM slides 8.9% to $2.47, a 6-month low
- Closed at $2.47, -8.86% vs the prior close of $2.71. Day range $2.46–$2.75, opened at $2.68.
- Volume was 190.41K shares, 0.8x its 50-day average of 241.84K.
- Price is -26.2% vs its 50-day average ($3.35) and -40.1% vs its 200-day average ($4.12).
- 52-week range $2.07–$15.50; today's close sits at 3% of that range, 84.1% below the 52-week high.
Oct 15, 2026 — QNTM rises 1.9% to $2.71
- Closed at $2.71, +1.88% vs the prior close of $2.66. Day range $2.60–$2.74, opened at $2.65.
- Volume was 107.40K shares, 0.4x its 50-day average of 241.52K — lighter than usual.
- Price is -19.4% vs its 50-day average ($3.36) and -34.6% vs its 200-day average ($4.15).
- 52-week range $2.07–$16.36; today's close sits at 4% of that range, 83.4% below the 52-week high.
Oct 14, 2026 — QNTM slides 8.0% to $2.66, a 6-month low
- Closed at $2.66, -7.96% vs the prior close of $2.89. Day range $2.66–$2.89, opened at $2.85.
- Volume was 180.30K shares, 0.7x its 50-day average of 242.51K.
- Price is -21.0% vs its 50-day average ($3.37) and -36.3% vs its 200-day average ($4.17).
- 52-week range $2.07–$16.36; today's close sits at 4% of that range, 83.7% below the 52-week high.
Oct 13, 2026 — QNTM rises 2.5% to $2.89
- Closed at $2.89, +2.48% vs the prior close of $2.82. Day range $2.80–$2.97, opened at $2.83.
- Volume was 82.80K shares, 0.3x its 50-day average of 241.75K — lighter than usual.
- Price is -14.3% vs its 50-day average ($3.37) and -31.2% vs its 200-day average ($4.20).
- 52-week range $2.07–$16.36; today's close sits at 6% of that range, 82.3% below the 52-week high.
Oct 12, 2026 — QNTM slides 4.1% to $2.82, a 6-month low, 3 down days in a row
- Closed at $2.82, -4.08% vs the prior close of $2.94. Day range $2.80–$3.00, opened at $2.98.
- Volume was 157.50K shares, 0.7x its 50-day average of 239.60K.
- Price is -16.4% vs its 50-day average ($3.37) and -33.3% vs its 200-day average ($4.23).
- 52-week range $2.07–$16.36; today's close sits at 5% of that range, 82.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — QNTM slides 5.5% to $2.94, a 1-month low
- Closed at $2.94, -5.47% vs the prior close of $3.11. Day range $2.94–$3.11, opened at $3.11.
- Volume was 129.50K shares, 0.5x its 50-day average of 237.98K — lighter than usual.
- Price is -12.9% vs its 50-day average ($3.38) and -31.0% vs its 200-day average ($4.26).
- 52-week range $2.07–$16.36; today's close sits at 6% of that range, 82.0% below the 52-week high.
Oct 8, 2026 — QNTM dips 1.1% to $3.11
- Closed at $3.11, -1.11% vs the prior close of $3.14. Day range $3.10–$3.23, opened at $3.10.
- Volume was 77.30K shares, 0.3x its 50-day average of 238.26K — lighter than usual.
- Price is -7.8% vs its 50-day average ($3.37) and -27.7% vs its 200-day average ($4.30).
- 52-week range $2.07–$17.50; today's close sits at 7% of that range, 82.2% below the 52-week high.
- SEC filings that day: 6-K.
Oct 7, 2026 — QNTM rises 1.8% to $3.14
- Closed at $3.14, +1.78% vs the prior close of $3.09. Day range $3.02–$3.16, opened at $3.07.
- Volume was 149.40K shares, 0.6x its 50-day average of 236.25K.
- Price is -6.6% vs its 50-day average ($3.37) and -27.4% vs its 200-day average ($4.33).
- 52-week range $2.07–$18.12; today's close sits at 7% of that range, 82.6% below the 52-week high.
Oct 6, 2026 — QNTM slides 5.5% to $3.09, a 1-month low on 2.8x normal volume
- Closed at $3.09, -5.50% vs the prior close of $3.27. Day range $3.05–$3.39, opened at $3.34.
- Volume was 618.80K shares, 2.8x its 50-day average of 224.50K — unusually heavy trading.
- Price is -8.2% vs its 50-day average ($3.36) and -29.1% vs its 200-day average ($4.36).
- 52-week range $2.07–$18.87; today's close sits at 6% of that range, 83.6% below the 52-week high.
- SEC filings that day: 6-K.
Oct 5, 2026 — QNTM slides 4.9% to $3.27
- Closed at $3.27, -4.94% vs the prior close of $3.44. Day range $3.25–$3.49, opened at $3.40.
- Volume was 245.90K shares, 1.1x its 50-day average of 220.33K.
- Price is -2.7% vs its 50-day average ($3.36) and -25.4% vs its 200-day average ($4.39).
- 52-week range $2.07–$19.00; today's close sits at 7% of that range, 82.8% below the 52-week high.
Oct 2, 2026 — QNTM rises 0.4% to $3.44
- Closed at $3.44, +0.44% vs the prior close of $3.42. Day range $3.32–$3.47, opened at $3.38.
- Volume was 79.20K shares, 0.4x its 50-day average of 222.36K — lighter than usual.
- Price is +2.5% vs its 50-day average ($3.36) and -22.0% vs its 200-day average ($4.41).
- 52-week range $2.07–$19.30; today's close sits at 8% of that range, 82.2% below the 52-week high.
QNTM latest news & SEC filings
Every SEC filing by or about QNTM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade QNTM
- How much it moves: over the last 20 sessions the average daily move was 3.85% (largest 8.9%). That is a volatile stock.
- Liquidity: about 207.21K shares (≈$511.81K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.47 vs a range of $2.07–$15.50 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 8, 2026; 6-K Oct 6, 2026; 6-K Sep 24, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
QNTM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.68 | 2.75 | 2.46 | 2.47 | 190.41K |
| Oct 15, 2026 | 2.65 | 2.74 | 2.60 | 2.71 | 107.40K |
| Oct 14, 2026 | 2.85 | 2.89 | 2.66 | 2.66 | 180.30K |
| Oct 13, 2026 | 2.83 | 2.97 | 2.80 | 2.89 | 82.80K |
| Oct 12, 2026 | 2.98 | 3.00 | 2.80 | 2.82 | 157.50K |
| Oct 9, 2026 | 3.11 | 3.11 | 2.94 | 2.94 | 129.50K |
| Oct 8, 2026 | 3.10 | 3.23 | 3.10 | 3.11 | 77.30K |
| Oct 7, 2026 | 3.07 | 3.16 | 3.02 | 3.14 | 149.40K |
| Oct 6, 2026 | 3.34 | 3.39 | 3.05 | 3.09 | 618.80K |
| Oct 5, 2026 | 3.40 | 3.49 | 3.25 | 3.27 | 245.90K |
| Oct 2, 2026 | 3.38 | 3.47 | 3.32 | 3.44 | 79.20K |
| Oct 1, 2026 | 3.56 | 3.66 | 3.40 | 3.42 | 82.70K |
| Sep 30, 2026 | 3.72 | 3.80 | 3.53 | 3.60 | 110.30K |
| Sep 29, 2026 | 3.95 | 3.96 | 3.71 | 3.82 | 119.60K |
| Sep 28, 2026 | 3.86 | 3.99 | 3.67 | 3.96 | 139.80K |
| Sep 25, 2026 | 4.00 | 4.00 | 3.80 | 3.85 | 193.40K |
| Sep 24, 2026 | 4.00 | 4.30 | 3.82 | 4.00 | 563.80K |
| Sep 23, 2026 | 3.65 | 4.34 | 3.65 | 3.88 | 643.80K |
| Sep 22, 2026 | 3.66 | 3.90 | 3.60 | 3.70 | 193.70K |
| Sep 21, 2026 | 3.65 | 3.82 | 3.52 | 3.61 | 78.60K |
About Quantum Biopharma
Quantum Biopharma (QNTM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TORONTO. State of incorporation: Ontario, Canada. Fiscal year ends December 31. SEC CIK 1771885.
QNTM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
QNTM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
QNTM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on QNTM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.